Q32 Bio QTTB
NASDAQ QTTB
$8.23 -0.02 (-0.24%)
At close: Oct 2, 2026 · 4:00 PM EDT

Q32 Bio (QTTB) Gains from Sales and Divestitures (2020 - 2023)

Updated

Q32 Bio (QTTB) posted Gains from Sales and Divestitures of $11.74 million for FY2025.

Analysis

Q32 Bio (QTTB) Gains from Sales and Divestitures (2020 - 2023) Analysis & Trends

Since FY2018, Q32 Bio has reported Gains from Sales and Divestitures for 7 years.

  • The FY2025 figure stands as the highest annual Gains from Sales and Divestitures since FY2022.
  • Business Quant data shows QTTB's Gains from Sales and Divestitures at $94,000 in FY2023 (-99.9%), $131.25 million in FY2022 and -$133,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Q32 Bio 195.35 Mn -78.94 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 162,000.00
Mar 31, 2023 -11,000.00
Mar 31, 2022 131.25 Mn
Dec 31, 2021 -127,000.00
Mar 31, 2021 -6,000.00
Dec 31, 2020 -888,000.00
API Access

Q32 Bio Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=QTTB&period=max&api_key=YOUR_API_KEY